ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PAR achieves 100 per cent recruitment in Phase 2b OA Trial
Published: 06/08/18, 09:16am (AEST)•3 pages